Luna Innovations (NASDAQ: LUNA) and Iqvia (NYSE:IQV) are both business services companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk and institutional ownership.
Institutional & Insider Ownership
22.7% of Luna Innovations shares are held by institutional investors. Comparatively, 89.8% of Iqvia shares are held by institutional investors. 10.6% of Luna Innovations shares are held by insiders. Comparatively, 6.0% of Iqvia shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
This is a summary of recent recommendations and price targets for Luna Innovations and Iqvia, as provided by MarketBeat.com.
||Strong Buy Ratings
Luna Innovations currently has a consensus price target of $3.25, indicating a potential upside of 9.06%. Iqvia has a consensus price target of $110.38, indicating a potential upside of 10.58%. Given Iqvia’s higher possible upside, analysts clearly believe Iqvia is more favorable than Luna Innovations.
Valuation and Earnings
This table compares Luna Innovations and Iqvia’s top-line revenue, earnings per share (EPS) and valuation.
||Earnings Per Share
Iqvia has higher revenue and earnings than Luna Innovations.
Volatility and Risk
Luna Innovations has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Comparatively, Iqvia has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500.
This table compares Luna Innovations and Iqvia’s net margins, return on equity and return on assets.
||Return on Equity
||Return on Assets
Iqvia beats Luna Innovations on 8 of the 13 factors compared between the two stocks.
Luna Innovations Company Profile
Luna Innovations Incorporated develops, manufactures, and markets fiber optic sensing, and test and measurement products worldwide. It operates in two segments, Products and Licensing, and Technology Development. The Products and Licensing segment offers fiber optic sensing products, as well as test and measurement products to monitor the integrity of fiber optic network components and sub-assemblies, which include optical vector analyzer, optical backscatter reflectometers, and the Phoenix family of tunable lasers; and distributed sensing systems comprising optical distributed sensor interrogator sensing solution with multiple sensors whose inputs are integrated through a fiber optic network and software. This segment also offers optoelectronic solutions for various applications, such as metrology, missile guidance, flame monitoring, temperature sensing, particle detection, color sensing, infrared detection, and other applications; and terahertz sensing systems, which are used to measure and verify physical properties online and in real-time. In addition, this segment conducts applied research in the fiber optic sensing area for corporate and government customers. The Technology Development segment provides applied research for customers principally in the areas of sensing and instrumentation, advanced materials, and health sciences. The company sells its products to telecommunications companies, defense agencies, government system integrators, researchers, original equipment manufacturers, distributors, testing labs, and strategic partners directly, as well as through manufacturer representative organizations, partner and distribution channels, technical sales engineers, value added resellers, and independent sales representatives. Luna Innovations Incorporated was founded in 1990 and is headquartered in Roanoke, Virginia.
Iqvia Company Profile
IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offers a range of cloud-based applications and related implementation, real-world insights, and reference information services; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order to life science companies, and investment and financial sectors that deal with life science companies; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level to pharmaceutical sales organizations. The Research & Development Solutions segment offers biopharmaceutical development services comprising project management and clinical monitoring, clinical trial support, and strategic planning and design services, as well as clinical trial, genomic, and bioanalytical laboratory services. The Integrated Engagement Services segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. The company serves pharmaceutical, biotechnology, device and diagnostic, and healthcare companies. IQVIA Holdings Inc. has a strategic alliance with MuleSoft, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Receive News & Ratings for Luna Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luna Innovations and related companies with MarketBeat.com's FREE daily email newsletter.